0.9% sodium chloride

Generic: 0.9% sodium chloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name 0.9% sodium chloride
Generic Name 0.9% sodium chloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

sodium chloride 9 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1359
Product ID 51662-1359_2b39daef-65ee-0aa7-e063-6394a90a364d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018803
Listing Expiration 2026-12-31
Marketing Start 2019-07-18

Pharmacologic Class

Classes
increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] osmotic activity [moa] osmotic laxative [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621359
Hyphenated Format 51662-1359

Supplemental Identifiers

RxCUI
1807631
UNII
451W47IQ8X

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name 0.9% sodium chloride (source: ndc)
Generic Name 0.9% sodium chloride (source: ndc)
Application Number NDA018803 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 9 mg/mL
source: ndc
Packaging
  • 50 mL in 1 VIAL, PLASTIC (51662-1359-1)
source: ndc

Packages (1)

51662-1359-1 50 mL in 1 VIAL, PLASTIC (51662-1359-1)

Ingredients (1)

sodium chloride (9 mg/mL)

Linked Drug Pages (1)

0.9% SODIUM CHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2b39daef-65ee-0aa7-e063-6394a90a364d", "openfda": {"unii": ["451W47IQ8X"], "rxcui": ["1807631"], "spl_set_id": ["8dfb05c0-77e8-2fa1-e053-2a95a90a3d33"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, PLASTIC (51662-1359-1)", "package_ndc": "51662-1359-1", "marketing_start_date": "20190718"}], "brand_name": "0.9% SODIUM CHLORIDE", "product_id": "51662-1359_2b39daef-65ee-0aa7-e063-6394a90a364d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]"], "product_ndc": "51662-1359", "generic_name": "0.9% SODIUM CHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "0.9% SODIUM CHLORIDE", "active_ingredients": [{"name": "SODIUM CHLORIDE", "strength": "9 mg/mL"}], "application_number": "NDA018803", "marketing_category": "NDA", "marketing_start_date": "20190718", "listing_expiration_date": "20261231"}